footnoted*

The company admits its news channels’ sexual harassment claims could take a toll.

Twitter’s use of a new phrase in recent earnings has caught our attention

Explaining executive raises following a controversy that sunk the stock gets awkward.

A recent arbitration decision hurt the company hard. More serious problems may be on the way.

A small biopharma company is hoping that its new CEO’s recent track record works a second time.

In the case of Valeant, a major investor paid a heavy price for ignoring the company’s endless Red Flags.

With no clear plan for ending or fixing Obamacare, a growing number of corporations are left guessing: “What’s next?”

We take a closer look at late filers and why they’re late (with XLS spreadsheet included).

The number of companies making disclosures about self-driving cars and trucks has exploded since the start of 2016.

Gun manufacturers disclosing slower sales under President Trump